MENU
+Compare
FOXO
Stock ticker: ASE
AS OF
Aug 8 closing price
Price
$0.11
Change
-$0.01 (-8.33%)
Capitalization
1.1M

FOXO stock forecast, quote, news & analysis

FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry... Show more

FOXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for FOXO with price predictions
Aug 08, 2025

FOXO's Indicator enters downward trend

The Aroon Indicator for FOXO entered a downward trend on August 08, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 224 similar instances where the Aroon Indicator formed such a pattern. In of the 224 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FOXO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +5 3-day Advance, the price is estimated to grow further. Considering data from situations where FOXO advanced for three days, in of 137 cases, the price rose further within the following month. The odds of a continued upward trend are .

FOXO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.113) is normal, around the industry mean (11.231). P/E Ratio (1.682) is within average values for comparable stocks, (80.335). FOXO's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.407). Dividend Yield (0.000) settles around the average of (0.063) among similar stocks. P/S Ratio (0.015) is also within normal values, averaging (85.405).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. FOXO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FOXO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.11B. The market cap for tickers in the group ranges from 52.04K to 46.1B. VEEV holds the highest valuation in this group at 46.1B. The lowest valued company is PPRG at 52.04K.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was 3%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 2%. PANHF experienced the highest price growth at 66%, while LFMD experienced the biggest fall at -31%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was 5%. For the same stocks of the Industry, the average monthly volume growth was 100% and the average quarterly volume growth was 27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 72
Price Growth Rating: 62
SMR Rating: 86
Profit Risk Rating: 93
Seasonality Score: -19 (-100 ... +100)
View a ticker or compare two or three
FOXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
729 Washington Avenue N
Phone
+1 612 562-9447
Employees
29
Web
https://www.foxolife.com